New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression
Authors
Keywords
Gastric cancer, Epstein–Barr virus (EBV), Microsatellite instability (MSI), Gene expression profiling, PD-L1
Journal
Gastric Cancer
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-05-19
DOI
10.1007/s10120-018-0836-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical relevance of molecular diagnostics in gastrointestinal (GI) cancer: European Society of Digestive Oncology (ESDO) expert discussion and recommendations from the 17th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona
- (2017) Alexander Baraniskin et al. EUROPEAN JOURNAL OF CANCER
- Lymphoepithelioma-like gastric carcinoma: clinicopathological characteristics and infection status
- (2017) Marcus Fernando Kodama Pertille Ramos et al. JOURNAL OF SURGICAL RESEARCH
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Host immune response index in gastric cancer identified by comprehensive analyses of tumor immunity
- (2017) Charny Park et al. OncoImmunology
- Programmed Death-Ligand 1 Expression Is Common in Gastric Cancer Associated With Epstein-Barr Virus or Microsatellite Instability
- (2016) Changqing Ma et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Immunotherapy in gastrointestinal cancer: Recent results, current studies and future perspectives
- (2016) Markus Moehler et al. EUROPEAN JOURNAL OF CANCER
- Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein–Barr virus status in a large cohort of gastric cancer patients
- (2016) Akihito Kawazoe et al. Gastric Cancer
- Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma
- (2016) Elizabeth D Thompson et al. GUT
- Expression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein-Barr virus–associated gastric carcinoma
- (2016) Min Dong et al. HUMAN PATHOLOGY
- PD-L1 expression is associated with massive lymphocyte infiltration and histology in gastric cancer
- (2016) Zhongwu Li et al. HUMAN PATHOLOGY
- Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
- (2016) Kei Muro et al. LANCET ONCOLOGY
- A protein and mRNA expression-based classification of gastric cancer
- (2016) Namrata Setia et al. MODERN PATHOLOGY
- Overexpression and gene amplification of PD-L1 in cancer cells and PD-L1+ immune cells in Epstein–Barr virus-associated gastric cancer: the prognostic implications
- (2016) Ruri Saito et al. MODERN PATHOLOGY
- Concordance of immune checkpoints within tumor immune contexture and their prognostic significance in gastric cancer
- (2016) Congqi Dai et al. Molecular Oncology
- Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers
- (2016) Keisuke Kataoka et al. NATURE
- Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
- (2016) Vassiliki A. Boussiotis NEW ENGLAND JOURNAL OF MEDICINE
- PD-L1 is an independent prognostic predictor in gastric cancer of Western patients
- (2016) Christine Böger et al. Oncotarget
- Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers
- (2016) Sarah Derks et al. Oncotarget
- CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer
- (2016) Shu Su et al. OncoImmunology
- Features of Gastric Carcinoma With Lymphoid Stroma Associated With Epstein-Barr Virus
- (2015) Hyun Lim et al. Clinical Gastroenterology and Hepatology
- Update on Epstein-Barr virus and gastric cancer (Review)
- (2015) AYA SHINOZAKI-USHIKU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Lymphoepithelioma-like carcinoma: A distinct type of gastric cancer
- (2015) Sungmin Park et al. JOURNAL OF SURGICAL RESEARCH
- Is gastric lymphoepithelioma-like carcinoma a special subtype of EBV-associated gastric carcinoma? New insight based on clinicopathological features and EBV genome polymorphisms
- (2014) Na Cheng et al. Gastric Cancer
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Biomarkers for gastric cancer: prognostic, predictive or targets of therapy?
- (2014) Cecília Durães et al. VIRCHOWS ARCHIV
- The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
- (2014) Nicolas J. Llosa et al. Cancer Discovery
- A miR-570 binding site polymorphism in the B7-H1 gene is associated with the risk of gastric adenocarcinoma
- (2013) Weipeng Wang et al. HUMAN GENETICS
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
- (2013) S. Spranger et al. Science Translational Medicine
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intrinsic Subtypes of Gastric Cancer, Based on Gene Expression Pattern, Predict Survival and Respond Differently to Chemotherapy
- (2011) Iain Beehuat Tan et al. GASTROENTEROLOGY
- A frequent somatic mutation in CD274 3′-UTR leads to protein over-expression in gastric cancer by disrupting miR-570 binding
- (2011) Weipeng Wang et al. HUMAN MUTATION
- Epstein-Barr virus-associated gastric carcinoma
- (2011) Masashi Fukayama et al. PATHOLOGY RESEARCH AND PRACTICE
- Modulation of Lymphocyte Regulation for Cancer Therapy: A Phase II Trial of Tremelimumab in Advanced Gastric and Esophageal Adenocarcinoma
- (2010) C. Ralph et al. CLINICAL CANCER RESEARCH
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- A combined histologic and molecular approach identifies three groups of gastric cancer with different prognosis
- (2009) Enrico Solcia et al. VIRCHOWS ARCHIV
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now